ÈËÉú¾ÍÊDz©ÊÖ»ú°æ

ÈËÉú¾ÍÊDz©ÊÖ»ú°æ

  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-08-07   ä¯ÀÀ´ÎÊý£º4617´Î
    ½üÈÕ£¬£¬£¬£¬£¬Í¬ÐÄÒ½ÁÆÃÀ¹úÈ«×Ê×Ó¹«Ë¾BrioHealth Solutions, Inc.°ä·¢¹«Ë¾×ÔÖ÷Ñз¢µÄÈ«´ÅÐü¸¡×óÐÄÊÒ¸¨ÖúϵͳBrioVADÔڳɹ¦ÊµÏÖÃÀ¹úINNOVATEÁÙ´²ÊÔÑ鰲ȫÐԽ׶Σ¨Safety Phase£©×êÑк󣬣¬£¬£¬£¬Õýʽ»ñµÃÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨The Food and Drug Administration, FDA£©ºË×¼½øÈëÈ·Ö¤ÐԽ׶Σ¨Pivotal Phase£©×êÑУ¬£¬£¬£¬£¬FDAÔ޳ɽ«ÁÙ´²×êÑÐÖÐÐÄÀ©´óµ½60¼Ò£¬£¬£¬£¬£¬²¢¿ÉÀÛ¼ÆÈë×é780ÃûÊÜÊÔÕߣ¨Ô̺¬°²È«ÐÔ½×¶ÎÊÜÊÔÕߣ©¡£¡£¡£¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-08-06   ä¯ÀÀ´ÎÊý£º4197´Î
    8ÔÂ5ÈÕ£¬£¬£¬£¬£¬ËØÓГͨÁɾ­¼Ã½ç°Â˹¿¨”Ö®³ÆµÄ2024Äê¶ÈͨÁɾ­¼Ã³É¾ÍÐû´«°ä²¼»î¶¯³É¹¦½øÐС£¡£¡£¡£¡£¡£¡£¡£Í¨ÁÉÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ“ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©”£¬£¬£¬£¬£¬301015.SZ)£©¶­Ê¡¢¸±×ܲᢲÆÕþ×ܼࡢ¶­Ê»áÃØÊéÀîÕðÏÈÉúƾ½èÔÚ¹«Ë¾ÖÎÀí¡¢±¾Ç®ÔË×÷¼°²úҵЭͬ·¢Õ¹·½ÃæµÄ͹Æð²û·¢£¬£¬£¬£¬£¬ÈÙ»ñ“2024Äê¶ÈͨÁɾ­¼ÃÐÂÈñÈËÎƺÅ¡£¡£¡£¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-07-25   ä¯ÀÀ´ÎÊý£º4902´Î
    ½üÈÕ£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©£¨301015.SZ£©ÆìÏÂ×ÔÓÐÆ·ÅÆNutraSummaÅ¦ÌØÊæÂêÕýÊ½ÍÆ³öÈ«ÐÂÒºÌåÒ¶»ÆËزúÆ·——GlowingPro£¨ÁÁ²©ÊÓ£©£¬£¬£¬£¬£¬¾Û½¹¶ùͯÀ¶¹â·À»¤ÓëÊÓÍøÄ¤½¡È«£¬£¬£¬£¬£¬ÒÔ´¿¾»Åä·½¡¢´´Ð¼ÁÐÍΪ¶ùͯȺÌåÌṩ¸ü°²È«¡¢¸ü±ã½ÝµÄ»¤ÑÛÓªÑø»¯¾ö¹æ»®¡£¡£¡£¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-07-09   ä¯ÀÀ´ÎÊý£º4843´Î
    2025Äê7ÔÂ5ÈÕÖÁ7ÈÕ£¬£¬£¬£¬£¬2025Ä꣨µÚ42½ì£©È«¹úÒ½Ò©¹¤ÒµÐÅÏ¢Äê»áÔÚ±±¾©½øÐС£¡£¡£¡£¡£¡£¡£¡£´ó»áÆÚ¼ä£¬£¬£¬£¬£¬“2025Äê¶ÈÖйúÒ½Ò©¹¤Òµ°ÙÇ¿ÆóÒµ”µÈϵÁаñµ¥³Á°õ°ä²¼¡£¡£¡£¡£¡£¡£¡£¡£ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©£¨301015.SZ£©¼Ì2024ÄêÈٵǓÖйúÒ½Ò©ÐÂÈñ´´ÉúÁ¦¾ü”°ñµ¥ºó£¬£¬£¬£¬£¬Æ¾½èÔÚ²úÆ·²¼¾Ö¡¢´´ÐÂϵͳÒÔ¼°Ã³Ò×»¯Æ½Ì¨½¨Éè·½ÃæµÄÓÅÒì²û·¢£¬£¬£¬£¬£¬ÔÙ¶ÈÈÙâß“2025ÄêÖйúÒ½Ò©Ñз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóÒµ”¡£¡£¡£¡£¡£¡£¡£¡£
  • Ê×Ò³-ÈËÉú¾ÍÊDz©ÊÖ»ú°æ
    2025-07-08   ä¯ÀÀ´ÎÊý£º5760´Î
    ½üÈÕ£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz©ÊÖ»ú°æÒ½Ò©Æì½¢Æ·ÅƵÏÇÉÔÙ¶È»ñµÃ¹ú¼ÊȨÍþµ÷Ñлú¹¹Å·î£¹ú¼Ê£¨Euromonitor International£©ÈÏÖ¤£¬£¬£¬£¬£¬Â½Ðø¾ÅÄêÎȾӹúÄÚ½ø¿Ú¸Æ²¹³ä¼ÁÊг¡µÚÒ»1¡£¡£¡£¡£¡£¡£¡£¡£¸ÃÈÏÖ¤²»½ö͹ÏÔÁ˵ÏÇÉÔÚ½ø¿Ú¸ÆÊг¡È·µ±ÏÈְ룬£¬£¬£¬£¬Ò²ÌåÏÖ³öÆäÔÚ²úÆ·´´Ð¡¢Êг¡ÍØÕ¹ºÍÆ·ÅÆ½¨Éè·½ÃæµÄ×ÛºÏʵÁ¦¡£¡£¡£¡£¡£¡£¡£¡£
·µ»Ø¶¥²¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿